SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter EquipmentCardiovascular Device

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2161906

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2161906

TAVR (Transcatheter Aortic Valve Replacement) Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 245 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 7295
Printable PDF & Excel (Enterprise License above 5 users)
USD 8495

Add to Cart

Description

Table of Contents

Introduction

Transcatheter aortic valve replacement has transformed the treatment of severe aortic stenosis, offering patients a way to receive a new heart valve without open-heart surgery. Using a catheter, typically inserted through an artery in the leg, physicians deliver a collapsible valve to the heart and deploy it inside the diseased native valve. In 2026, the market is valued at US$7.2 Bn and is projected to reach US$14 Bn by 2033, registering a CAGR of 9.97%. Originally reserved for patients considered too frail for surgery, the procedure has steadily expanded to intermediate and low-risk groups as clinical evidence has accumulated. Ageing populations are increasing the number of people living with calcific aortic stenosis, and better diagnosis is identifying patients who previously went untreated. Device designs continue to improve in deliverability, sizing and durability, while hospitals and specialist cardiac centres build structured heart teams to manage growing procedure volumes. These factors are making the procedure a mainstream therapy in structural heart care worldwide.

Market Insights

The market is segmented by valve type, access route, patient risk category and end user. Valve types include balloon-expandable valves, self-expanding valves, and mechanically expanded and other valve designs. Access routes cover transfemoral, transaxillary and subclavian, transapical, and transaortic and other alternative approaches. Patient risk categories span inoperable, high-risk, intermediate-risk and low-risk groups, while end users include hospitals, cardiac specialty centres, and academic and research institutes. Between 2020 and 2025, the market grew at about 11.2% CAGR, somewhat faster than the forecast pace as the market matures. The low-risk category is the fastest-growing at 13.8% CAGR, reflecting the extension of the therapy to younger and healthier patients. Self-expanding valves lead valve type growth at 10.6% CAGR, transaxillary and subclavian access is the fastest route at 11.0% CAGR, and cardiac specialty centres are the fastest-growing end user at 11.2% CAGR. Historically, two manufacturers have accounted for most implants, although newer entrants are gradually widening the choice of platforms available to clinicians.

Drivers

The progressive widening of indications across surgical risk categories is the principal driver, with high impact over the long term. Each step from inoperable to high, intermediate and now low-risk patients has substantially enlarged the eligible population, and clinicians increasingly consider transcatheter replacement as a first-line option. This trend continues to lift procedure volumes as guidelines and referral patterns adjust. The second driver is the ageing of populations, which is increasing the prevalence of severe calcific aortic stenosis, also a high-impact, long-term force. As more people live into their seventies and eighties, the number of patients needing valve treatment rises steadily. Restraints remain important. Long-term valve durability and lifetime management questions are still being answered, particularly for younger patients who may need more than one valve over their lives, a high-impact, long-term issue. In addition, requirements for heart teams, minimum institutional volumes and reimbursement conditions limit how quickly new centres can open, a medium-impact constraint over the medium term that slows broader access.

Business Opportunity

Treating undertreated and newly detected severe aortic stenosis offers a major opportunity to expand the eligible patient pool. Many patients with the condition are never referred for valve replacement, either because symptoms are attributed to ageing or because diagnosis is delayed. Wider use of screening, improved echocardiography pathways and awareness programmes can bring these patients into treatment, increasing procedure volumes without relying solely on new indications. Manufacturers, hospitals and referral networks that work together to close this treatment gap can unlock significant additional demand. A second opportunity lies in dedicated platforms for bicuspid anatomy and small annuli. Patients with a bicuspid valve or a small aortic annulus present specific technical challenges, and devices designed for their anatomy can improve outcomes and procedural confidence. This specialised device segment is particularly relevant in Asia Pacific, where such anatomical characteristics are commonly encountered. Companies that develop and validate tailored designs for these groups can differentiate their portfolios and gain share in fast-growing markets over the forecast period.

Region Analysis

North America leads the market with a 52.0% share in 2026, supported by early adoption, broad clinical evidence, established reimbursement and a large network of experienced heart teams. Europe holds 27%, where the procedure is widely used and growth depends on referral pathways and national reimbursement decisions. Asia Pacific accounts for 14.5% and is the fastest-growing region at 13.2% CAGR, driven by ageing populations, expanding cardiac centre capacity, rising awareness of structural heart disease and increasing availability of platforms suited to regional anatomy. Latin America represents 3.5%, with adoption concentrated in leading urban hospitals and limited by reimbursement and cost. The Middle East and Africa holds 3.0%, where procedure volumes are growing from a small base in specialised centres. Across these five regions, the availability of trained heart teams, reimbursement frameworks and diagnostic pathways will determine how quickly more patients gain access to transcatheter valve replacement, and regions that expand specialist capacity are likely to see the strongest gains.

Key Players

  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • JenaValve Technology, Inc.
  • Venus Medtech (Hangzhou) Inc.
  • Peijia Medical Limited
  • MicroPort Scientific Corporation
  • Braile Biomedica

Segmentation

By Valve Type:

  • Balloon-Expandable Valves
  • Self-Expanding Valves
  • Mechanically-Expanded and Other Valve Designs

By Access Route:

  • Transfemoral Access
  • Transaxillary and Subclavian Access
  • Transapical Access
  • Transaortic and Other Alternative Access

By Patient Risk Category:

  • Inoperable
  • High-Risk
  • Intermediate-Risk
  • Low-Risk

By End User:

  • Hospitals
  • Cardiac Specialty Centers
  • Academic and Research Institutes

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global TAVR (Transcatheter Aortic Valve Replacement) Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, 2020-2033

  • 3.1. Global TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Balloon-Expandable Valves
    • 3.1.2. Self-Expanding Valves
    • 3.1.3. Mechanically-Expanded and Other Valve Designs
  • 3.2. Global TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, Value (US$ Bn), 2020-2033
    • 3.2.1. Transfemoral Access
    • 3.2.2. Transaxillary and Subclavian Access
    • 3.2.3. Transapical Access
    • 3.2.4. Transaortic and Other Alternative Access
  • 3.3. Global TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, Value (US$ Bn), 2020-2033
    • 3.3.1. Inoperable
    • 3.3.2. High-Risk
    • 3.3.3. Intermediate-Risk
    • 3.3.4. Low-Risk
  • 3.4. Global TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Cardiac Specialty Centers
    • 3.4.3. Academic and Research Institutes
  • 3.5. Global TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, 2020-2033

  • 4.1. North America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Balloon-Expandable Valves
    • 4.1.2. Self-Expanding Valves
    • 4.1.3. Mechanically-Expanded and Other Valve Designs
  • 4.2. North America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, Value (US$ Bn), 2020-2033
    • 4.2.1. Transfemoral Access
    • 4.2.2. Transaxillary and Subclavian Access
    • 4.2.3. Transapical Access
    • 4.2.4. Transaortic and Other Alternative Access
  • 4.3. North America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, Value (US$ Bn), 2020-2033
    • 4.3.1. Inoperable
    • 4.3.2. High-Risk
    • 4.3.3. Intermediate-Risk
    • 4.3.4. Low-Risk
  • 4.4. North America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Cardiac Specialty Centers
    • 4.4.3. Academic and Research Institutes
  • 4.5. North America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 4.5.2. U.S. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 4.5.3. U.S. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 4.5.4. U.S. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 4.5.5. Canada TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 4.5.6. Canada TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 4.5.7. Canada TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 4.5.8. Canada TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, 2020-2033

  • 5.1. Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Balloon-Expandable Valves
    • 5.1.2. Self-Expanding Valves
    • 5.1.3. Mechanically-Expanded and Other Valve Designs
  • 5.2. Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, Value (US$ Bn), 2020-2033
    • 5.2.1. Transfemoral Access
    • 5.2.2. Transaxillary and Subclavian Access
    • 5.2.3. Transapical Access
    • 5.2.4. Transaortic and Other Alternative Access
  • 5.3. Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, Value (US$ Bn), 2020-2033
    • 5.3.1. Inoperable
    • 5.3.2. High-Risk
    • 5.3.3. Intermediate-Risk
    • 5.3.4. Low-Risk
  • 5.4. Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Cardiac Specialty Centers
    • 5.4.3. Academic and Research Institutes
  • 5.5. Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.2. Germany TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.3. Germany TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.4. Germany TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 5.5.5. Italy TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.6. Italy TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.7. Italy TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.8. Italy TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 5.5.9. France TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.10. France TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.11. France TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.12. France TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 5.5.13. U.K. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.14. U.K. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.15. U.K. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.16. U.K. TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 5.5.17. Spain TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.18. Spain TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.19. Spain TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.20. Spain TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 5.5.21. Russia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.22. Russia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.23. Russia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.24. Russia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 5.5.25. Rest of Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 5.5.26. Rest of Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 5.5.27. Rest of Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 5.5.28. Rest of Europe TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, 2020-2033

  • 6.1. Asia Pacific TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Balloon-Expandable Valves
    • 6.1.2. Self-Expanding Valves
    • 6.1.3. Mechanically-Expanded and Other Valve Designs
  • 6.2. Asia Pacific TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, Value (US$ Bn), 2020-2033
    • 6.2.1. Transfemoral Access
    • 6.2.2. Transaxillary and Subclavian Access
    • 6.2.3. Transapical Access
    • 6.2.4. Transaortic and Other Alternative Access
  • 6.3. Asia Pacific TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, Value (US$ Bn), 2020-2033
    • 6.3.1. Inoperable
    • 6.3.2. High-Risk
    • 6.3.3. Intermediate-Risk
    • 6.3.4. Low-Risk
  • 6.4. Asia Pacific TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Cardiac Specialty Centers
    • 6.4.3. Academic and Research Institutes
  • 6.5. Asia Pacific TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 6.5.2. China TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 6.5.3. China TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 6.5.4. China TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 6.5.5. Japan TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 6.5.6. Japan TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 6.5.7. Japan TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 6.5.8. Japan TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 6.5.9. South Korea TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 6.5.10. South Korea TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 6.5.11. South Korea TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 6.5.12. South Korea TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 6.5.13. India TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 6.5.14. India TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 6.5.15. India TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 6.5.16. India TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 6.5.17. Southeast Asia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 6.5.18. Southeast Asia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 6.5.19. Southeast Asia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 6.5.20. Southeast Asia TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 6.5.21. Rest of SAO TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 6.5.22. Rest of SAO TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 6.5.23. Rest of SAO TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 6.5.24. Rest of SAO TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, 2020-2033

  • 7.1. Latin America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Balloon-Expandable Valves
    • 7.1.2. Self-Expanding Valves
    • 7.1.3. Mechanically-Expanded and Other Valve Designs
  • 7.2. Latin America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, Value (US$ Bn), 2020-2033
    • 7.2.1. Transfemoral Access
    • 7.2.2. Transaxillary and Subclavian Access
    • 7.2.3. Transapical Access
    • 7.2.4. Transaortic and Other Alternative Access
  • 7.3. Latin America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, Value (US$ Bn), 2020-2033
    • 7.3.1. Inoperable
    • 7.3.2. High-Risk
    • 7.3.3. Intermediate-Risk
    • 7.3.4. Low-Risk
  • 7.4. Latin America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Cardiac Specialty Centers
    • 7.4.3. Academic and Research Institutes
  • 7.5. Latin America TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 7.5.2. Brazil TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 7.5.3. Brazil TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 7.5.4. Brazil TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 7.5.5. Mexico TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 7.5.6. Mexico TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 7.5.7. Mexico TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 7.5.8. Mexico TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 7.5.9. Argentina TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 7.5.10. Argentina TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 7.5.11. Argentina TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 7.5.12. Argentina TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 7.5.13. Rest of LATAM TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 7.5.14. Rest of LATAM TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 7.5.15. Rest of LATAM TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 7.5.16. Rest of LATAM TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, 2020-2033

  • 8.1. Middle East & Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Balloon-Expandable Valves
    • 8.1.2. Self-Expanding Valves
    • 8.1.3. Mechanically-Expanded and Other Valve Designs
  • 8.2. Middle East & Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, Value (US$ Bn), 2020-2033
    • 8.2.1. Transfemoral Access
    • 8.2.2. Transaxillary and Subclavian Access
    • 8.2.3. Transapical Access
    • 8.2.4. Transaortic and Other Alternative Access
  • 8.3. Middle East & Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, Value (US$ Bn), 2020-2033
    • 8.3.1. Inoperable
    • 8.3.2. High-Risk
    • 8.3.3. Intermediate-Risk
    • 8.3.4. Low-Risk
  • 8.4. Middle East & Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Cardiac Specialty Centers
    • 8.4.3. Academic and Research Institutes
  • 8.5. Middle East & Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 8.5.2. GCC TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 8.5.3. GCC TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 8.5.4. GCC TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 8.5.5. South Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 8.5.6. South Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 8.5.7. South Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 8.5.8. South Africa TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 8.5.9. Egypt TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 8.5.10. Egypt TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 8.5.11. Egypt TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 8.5.12. Egypt TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 8.5.13. Nigeria TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 8.5.14. Nigeria TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 8.5.15. Nigeria TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 8.5.16. Nigeria TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
    • 8.5.17. Rest of Middle East TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Valve Type, 2020-2033
    • 8.5.18. Rest of Middle East TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Access Route, 2020-2033
    • 8.5.19. Rest of Middle East TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by Patient Risk Category, 2020-2033
    • 8.5.20. Rest of Middle East TAVR (Transcatheter Aortic Valve Replacement) Market Outlook, by End User, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Edwards Lifesciences Corporation
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Medtronic plc
    • 9.4.3. Abbott Laboratories
    • 9.4.4. Boston Scientific Corporation
    • 9.4.5. Meril Life Sciences Pvt. Ltd.
    • 9.4.6. JenaValve Technology, Inc.
    • 9.4.7. Venus Medtech (Hangzhou) Inc.
    • 9.4.8. Peijia Medical Limited
    • 9.4.9. MicroPort Scientific Corporation
    • 9.4.10. Braile Biomedica

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!